• Women make up roughly 28% of on-course golfers in the United States, a historic high.
• The global golf equipment market is booming, generating an estimated $25.5 billion in 2024 and projected to grow at nearly 6% annually.
• Newton Golf’s lighter shaft is engineered to weigh less than previous versions while maintaining precision, stability and distance.

A surge in women’s golf participation is reshaping the industry, drawing fresh energy and opportunity to equipment manufacturers. Newton Golf Company (NASDAQ: NWTG) recently released the perfect piece of equipment for this dynamic market — a lighter shaft option, designed to deliver premium performance for golfers of all levels, from weekend enthusiasts to tour professionals, who are widely adopting the new shaft in competition.

Women now make up roughly 28% of on-course golfers in the United States, a historic high, with female participation climbing 41% since 2019 to reach 7.9 million players in 2024 (https://ibn.fm/d1HkS). Notably, younger women are entering the sport in record numbers through recreational and social formats such as high-tech driving ranges and simulator venues, which are removing historical barriers and making golf more accessible and inclusive (https://ibn.fm/dAPel).

This demographic shift has created a powerful marketplace. Women’s golf equipment and apparel purchases reached $1.53 billion in the United States in 2021, underscoring the purchasing influence of female golfers (https://ibn.fm/FzNMx). In addition, the global golf equipment market is on track to expand from $29.03 billion in 2024 to $30.41 billion in 2025, growing at a 4.8% compound annual growth rate (“CAGR”) (https://ibn.fm/Wgvsx). These trends highlight the critical role that women have in the space, not only as players but as a driving force in golf’s commercial growth.

Newton Golf’s introduction of its lighter shaft further aligns with shifting market dynamics. The new option is engineered to weigh less than previous versions while maintaining precision, stability and distance (https://ibn.fm/4qUhj) — qualities valued by golfers across all demographics. With growing participation from women, juniors and recreational players seeking both performance and comfort, the new shaft offers an adaptable solution suited to evolving needs, without being marketed toward a single group. It’s designed for any golfer looking for enhanced swing speed and control through weight reduction and refined balance.

Newton Golf has built its reputation on innovation, focusing on advanced shaft technologies that address fundamental aspects of the golf swing. The company’s Missouri-based manufacturing hub ensures U.S.-based quality and responsiveness to market trends. The new lighter shaft was introduced to support golfers’ desire for equipment that facilitates improved biomechanics and enhanced playability, especially for those experiencing slower swing speeds or seeking greater consistency.

While Newton Golf remains popular among the amateur circuit, the company has also secured endorsement from touring professionals, signaling that its technology can meet elite standards (https://ibn.fm/l2FGm). As women’s golf continues to gain prominence with increased media coverage, investment and female-driven grassroots programs, providing high-performance equipment options across skill levels is becoming increasingly important.

As women continue to drive golf’s growth and redefine its culture and commerce, having manufacturers such as Newton Golf focus on thoughtful gear advancement is key. The new lighter shaft represents not only technological progress but also an industry adapting to the sport’s new face — and all the golfers who comprise it.

For more information, visit www.NewtonGolfCo.com.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG

• Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and Japan.
• Even with treatment, symptoms can continue occurring for many patients and significantly affect their quality of life and productivity.
• Soligenix has initiated a clinical trial to evaluate the safety, tolerability and preliminary efficacy of SGX945 in patients suffering from oral ulcers.

Behçet’s disease is a rare, chronic autoimmune disorder characterized by inflammation of blood vessels, leading to a range of symptoms including painful mouth and genital ulcers, eye inflammation and skin lesions. With limited treatment options available, Soligenix (NASDAQ: SNGX) is at the forefront of developing innovative therapies, notably SGX945 (dusquetide), aiming to address the unmet need in this challenging disease landscape (https://ibn.fm/KByRu).

Behçet’s disease is rare, with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Europe. It’s more prevalent in countries along the Silk Road, including Türkiye, Iran, and Japan. In Türkiye, prevalence can range from 80 to 370 per 100,000. Symptoms of the disease include mouth sores, eye irritation and swelling, skin rashes and sores, and genital sores (https://ibn.fm/Hxv0M).

Behçet’s disease is believed to be an autoimmune illness with both genetic and environmental components. Symptoms are most severe in young adulthood and generally ameliorate with age. While the aphthous ulcers of Behçet’s disease are extremely painful, they are not usually associated with long-term damage, although scarring is a prevalent concern. More rarely, Behçet’s disease can affect other organ systems, such as the eyes, lungs, and brain, and may even become life threatening. 

Treatment involves medications designed to ease symptoms and prevent serious complications, such as blindness. Even with treatment, oral and genital flares can continue to occur for many patients and significantly affect quality of life and productivity. In addition, treatments can be associated with adverse effects, underscoring the need for more targeted and effective therapies.

Soligenix is addressing this therapeutic gap through the development of SGX945, an investigational drug designed to modulate the body’s innate immune response. SGX945 is a synthetic peptide that enhances the resolution of inflammation and promotes tissue healing without suppressing the immune system. Preclinical studies have demonstrated its potential in reducing inflammation and accelerating healing in various models.

Soligenix has initiated a phase 2a clinical trial to evaluate the safety, tolerability and preliminary efficacy of SGX945 in patients with Behçet’s disease suffering from oral ulcers (https://ibn.fm/krror). This small, open-label, proof-of-concept study is enrolling patients at a single center in Türkiye. The efficacy endpoint focuses on the reduction in the number and duration of oral ulcers, while secondary efficacy endpoints include assessments of pain reduction and overall disease activity. The trial’s design reflects a comprehensive approach to understanding SGX945’s therapeutic potential in this patient population.

Soligenix’s commitment to advancing SGX945 aligns with its broader mission to develop and commercialize products that address unmet medical needs in rare diseases. The company’s pipeline includes a range of product candidates targeting inflammatory conditions and biodefense indications. SGX945’s development represents a significant step toward providing a novel, non-immunosuppressive treatment option for patients with Behçet’s disease, potentially improving quality of life and disease management.

As the phase 2a trial progresses, the medical community remains attentive to the outcomes, which could herald a new era in the treatment of Behçet’s disease. Soligenix’s innovative approach exemplifies the potential of targeted therapies in addressing complex autoimmune conditions, offering hope to patients and clinicians seeking more effective and safer treatment alternatives.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

• LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
• The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
• Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
• LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
• A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (“tpd”), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (“TSX”) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (“AEMQ”). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (“IGOPP”) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

• Platinum prices have recently reached their highest levels in more than two years.
• Palladium has also seen renewed interest as industrial demand stabilizes and inflation pressures persist.
• Platinum Group Metals Ltd. stands out due to its advanced-stage project, strong partnerships and commitment to innovation.

In recent weeks, platinum and palladium prices have gained considerable momentum, driven largely by a resurgence in demand from China’s jewelry sector and increasing concern over global supply constraints. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a development-stage mining company focused exclusively on platinum group metals (“PGMs”), is well positioned to capitalize on these favorable conditions. With a strong asset base and an advanced development project in South Africa, the company is pursuing a strategic path toward becoming an important supplier in a resurging PGM market.

Platinum prices have recently reached their highest levels in more than two years, trading above $1,095 per ounce, up more than 20% year-to-date (https://ibn.fm/GAzra). This rally has been fueled by a notable uptick in Chinese demand, particularly for platinum jewelry, which had previously lagged behind gold due to shifting consumer preferences. According to the World Platinum Investment Council (“WPIC”), China’s jewelry demand for platinum is expected to grow by 5% in 2025, reaching approximately 2.1 million ounces, as consumers take advantage of platinum’s price discount relative to gold. The shift follows a significant run-up in gold prices, leading value-conscious buyers back to platinum, which many consider to have similar aesthetic appeal and long-term intrinsic value (https://ibn.fm/m69AL, https://ibn.fm/cXDkM).

At the same time, palladium — a sister metal to platinum and an essential component in automotive catalytic converters — has also seen renewed interest as industrial demand stabilizes and inflation pressures persist (https://ibn.fm/Ww9BQ). China’s continued investment in automobile production, alongside gradual post-pandemic global recovery in vehicle manufacturing, has supported palladium’s rebound. Moreover, both metals are integral to emerging technologies such as hydrogen fuel cells and next-generation batteries, adding future demand potential beyond traditional uses.

Against this backdrop, Platinum Group Metals is making meaningful strides through its flagship Waterberg Project, a large-scale palladium-dominant deposit located on the Northern Limb of South Africa’s renowned Bushveld Igneous Complex. The company holds an effective 50.16% interest in the project, which is joint ventured with industry heavyweights Impala Platinum Holdings Limited (“Implats”), Hanwa Co. Ltd. and the Japan Organization for Metals and Energy Security (“JOGMEC”).

The Waterberg Project represents one of the few large-scale, greenfield PGM developments globally and is uniquely designed for mechanized, bulk underground mining. This differentiates it from traditional labor-intensive operations and makes it more attractive from a cost, safety and scalability perspective. A 2024 update to the Definitive Feasibility Study (“DFS”) outlined a 20% increase in proven and probable mineral reserves, extending the mine’s estimated life from 45 years to 54 years and confirming 23.4 million 4E ounces (platinum, palladium, rhodium, and gold) in reserves (https://ibn.fm/IBshz). The DFS also cited an after-tax net present value (“NPV”) of $569 million and an internal rate of return (“IRR”) of 14.2% using long-term consensus pricing, figures that underscore the project’s economic viability.

Beyond mining, Platinum Group Metals is investing in the future of PGMs through its partnership with Valterra Platinum to develop next-generation battery technologies (https://ibn.fm/DAcyx). This collaboration is focused on leveraging PGMs in energy storage applications, specifically targeting advancements in lithium-sulfur battery technology. Such innovations could open up entirely new demand verticals for platinum and palladium, aligning with global decarbonization trends and increasing interest in alternative energy storage systems.

While many mining companies are still navigating the regulatory and funding challenges of bringing new operations online, Platinum Group Metals stands out due to its advanced-stage project, strong partnerships and commitment to innovation. As global markets look to diversify away from risky supply chains and reduce dependence on any single geographic source, the Waterberg Project’s location and development plan make it a strategically important resource in the global PGM landscape.

The company’s progress is well timed. With China’s demand for platinum jewelry showing strong signs of recovery, and both platinum and palladium gaining traction across industrial and clean energy applications, the market outlook is increasingly favorable for companies capable of delivering high-quality supply. Platinum Group Metals is not only responding to today’s demand surge but also preparing to support the next phase of global economic and technological evolution with responsibly sourced, strategically important metals.

For more information, visit www.PlatinumGroupMetals.net.

NOTE TO INVESTORS: The latest news and updates relating to PLG are available in the company’s newsroom at https://ibn.fm/PLG

• HeartBeam has developed the first cable-free system capable of synthesizing a 12-lead ECG from 3D, non-coplanar electrical signals captured in real time.
• Patients can have the HeartBeam System with them at all times, ready to record an ECG in 30 seconds at home or anywhere when they feel symptoms to reduce delays in care.
• The HeartBeam System is now FDA cleared for arrhythmia assessment, with additional FDA review underway for its 12-lead ECG synthesis software for the same indication.
• A recent partnership with AccurKardia enhances HeartBeam’s arrhythmia solution with an FDA-cleared automated rhythm interpretation software.
• HeartBeam holds 20 issued patents, with additional allowed and pending applications, protecting its proprietary hardware, software, and algorithmic capabilities.
• Commercial launch is expected to be imminent, targeting a $500 million concierge SAM and broader multibillion-dollar patient pay market, supported by a high-margin, recurring revenue model.

HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. The company is creating the first ever cable-free synthesized 12-lead ECG platform designed to give patients the ability to record their symptoms the moment they occur, wherever they are. By providing synthesized, 12-lead ECG data, physicians can quickly assess the symptoms and ensure patients get the care they need in a timely manner. It also eliminates the need for wires, complex setup, or clinical staff, thus allowing synthesized 12-lead ECG signals to be accessible outside of a medical setting.

HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical decisions outside the confines of a traditional medical setting. Its patented approach not only delivers similar, but not identical, accuracy of conventional 12-lead ECGs for arrhythmia detection but also unlocks future capabilities in ischemia detection, AI-assisted analysis, and longitudinal cardiac trend tracking.

The HeartBeam System is now FDA cleared for arrhythmia assessment, following foundational 510(k) clearance granted in December 2024. The company submitted a 510(k) application for its 12-lead ECG synthesis software in January 2025 for arrhythmia assessment. As it approaches commercialization, HeartBeam is executing a multi-phase go-to-market strategy with initial U.S. rollout plans and a focus on high-margin, recurring revenue.

The company is headquartered in Santa Clara, California.

Products

HeartBeam’s flagship product is a credit card-sized, cable-free device designed to capture ECG signals in three non-coplanar directions and transform them into synthesized 12-lead ECGs. This novel form factor integrates a smartphone app, cloud connectivity, and a physician portal, enabling patients to record cardiac events at the moment symptoms occur and physicians to assess and triage in near real time.

The device is supported by an expanding software ecosystem. A key component of this is HeartBeam’s proprietary 12-lead ECG synthesis software, which met its clinical endpoint in the  VALID-ECG pivotal study with 93.4% manual diagnostic agreement for arrhythmia assessment. This software is currently under FDA review and is designed to deliver clinical-grade arrhythmia diagnostic capabilities outside of traditional healthcare environments.

In April 2025, HeartBeam announced a strategic partnership with AccurKardia to incorporate its FDA-cleared ECG analysis software, AccurECG(TM), into HeartBeam’s offering. This integration is expected to enhance automated rhythm interpretation, streamline physician workflows, and improve diagnostic speed and accuracy.

Additional form factors are under development, including an on-demand synthesized 12-lead patch with issued patents, intended to serve the extended-wear market segment. These complementary offerings are intended to support chronic disease management and continuous monitoring applications, broadening HeartBeam’s total product ecosystem in the future.

Market Opportunity

HeartBeam is targeting large and growing segments within the $20 billion+ global cardiac monitoring and diagnostics market. According to the company’s own materials, the U.S. concierge care segment alone represents a $500 million serviceable addressable market (“SAM”), comprising approximately 1.5 million patients—500,000 of whom are at elevated cardiac risk. This initial focus provides a strategic entry point for cash-pay and early adoption.

Expanding beyond this niche, HeartBeam identifies a $1.3 billion to $2.6 billion annual opportunity in the broader U.S. direct patient pay market, driven by more than 2.6 million high-income individuals aged 35–74 with elevated cardiac risk. For comparison, more than 2.5 million Oura rings and over 3 million AliveCor Kardia devices have been sold, demonstrating strong consumer willingness to adopt personal cardiac technologies.

HeartBeam’s long-term opportunity is significantly larger. The company estimates that over 20 million people in the U.S. are at high risk for myocardial infarction (“MI”), representing a total addressable market nearly 40 times greater than the concierge segment. Additionally, the company’s on-demand 12-lead patch aims to capture market share in the extended wear and mobile cardiac telemetry (“MCOT”) space, competing with incumbents like iRhythm, Boston Scientific, Philips, and Baxter.

Leadership Team

Robert P. Eno, Chief Executive Officer and Director, brings over 30 years of experience launching disruptive medical technologies and leading commercialization efforts. He has held executive roles at HeartFlow, OptiMedica, NeoGuide Systems, and Avantec Vascular, and holds an MBA and BA from Stanford University.

Branislav Vajdic, PhD, President and Founder, is a seasoned innovator with over three decades of experience in technology and device development. He co-invented flash memory at Intel and led engineering teams responsible for the Pentium processor series. He previously served as CEO of NewCardio and holds a PhD in Electrical Engineering from the University of Minnesota.

Timothy Cruickshank, Chief Financial Officer, has over 15 years of experience in financial and strategic leadership roles. Formerly CFO at ImpediMed, he transformed the company into a SaaS-driven model. He holds an MBA from Keller Graduate School and a BS in Accounting from Syracuse University.

Peter J. Fitzgerald, MD, PhD, Chief Medical Officer, is a Stanford professor emeritus and interventional cardiologist with leadership in over 175 clinical trials and 24 medical startups. He co-founded TriVentures and has advised the FDA for over 20 years.

Ken Persen, Chief Technology Officer, has more than 25 years of experience in cardiac and digital health technology, including founding LIVMOR and leadership roles at Guidant and Cameron Health. He specializes in system design and product engineering for connected cardiac solutions.

For more information, visit the company’s website at www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

• ONAR’s core focus is to accelerate revenue for middle-market companies via AI technology, innovation and digital excellence
• CEO notes that middle-market companies are in one of the most exciting yet demanding phases of growth
• ONAR follows a business model designed to be fast-moving, flexible and focused on delivering results, precisely what the middle-market sector needs

ONAR Holding Corp. (OTCQB: ONAR) is staking its claim as a leader in AI-driven marketing, as CEO Claude Zdanow discusses the company’s powerful strategy to support middle-market firms through intelligent, data-focused innovation. In a recent Digital Journal interview, Zdanow detailed ONAR’s mission to deliver integrated, tech-first marketing solutions tailored to growth-stage enterprises (ibn.fm/9ysN6).

Throughout the conversation, Zdanow emphasized ONAR’s core focus: accelerating revenue for middle-market companies via artificial intelligence (“AI”), innovation and digital excellence. “ONAR is a marketing technology company and agency network built specifically for middle-market businesses that are ready to grow,” stated Zdanow. “We sit in a unique space that’s not quite a traditional agency and not just a SaaS platform, but something in between. Our model blends strategic services, AI-driven insights and scalable execution to give companies the tools and support they need to scale quickly and smartly.”

Zdanow noted that middle-market companies are in one of the most exciting yet demanding phases of growth. “They need to scale quickly, perform under pressure and often do more with less. While they’re too large for DIY marketing tools, they’re too lean to rely on massive agency teams. That’s where ONAR’s network comes in and fills the gap,” he said.

Zdanow explained that ONAR follows a business model designed to be fast-moving, flexible and focused on delivering results, precisely what this sector needs. “Middle-market leaders are builders who need partners that can keep pace with their needs, not overengineered solutions or slow-moving firms,” he stated. “They want agility and expertise, which is exactly what our agencies provide.”

ONAR recognizes that these companies are a key element of the economy, but they often face a challenge: they need sophisticated solutions but lack the resources for enterprise-level agency relationships. “ONAR bridges that gap by combining top-tier strategic thinking with the agility, transparency and cost-efficiency that middle-market businesses need,” Zdanow said. “Our agencies’ clients aren’t just looking for a vendor, they want a partner who truly understands their stage and speed.”

“ONAR is purpose-built for the middle market, where innovation meets hustle,” he continued. “Having built businesses from the ground up, we know that these companies need nimble, high-touch support, not complex, overcomplicated solutions. We provide deep expertise and enterprise-grade capabilities without red tape, moving at their speed, speaking their language and staying deeply invested in their success.”

ONAR Holding Corporation is leading a dynamic transformation in how middle-market businesses harness marketing technology. From a foundation in marketing to a robust future-driven strategy rooted in AI, ONAR’s story reflects the power of data, digital innovation and targeted agency partnerships. The company’s innovative ONAR Labs, a dedicated division focused on identifying, developing and commercializing innovative marketing technology solutions, the company is well-positioned to lead the next wave of AI-driven marketing innovation, making middle-market excellence a scalable reality.

For more information, visit the company’s website at www.ONAR.com.

NOTE TO INVESTORS: The latest news and updates relating to ONAR are available in the company’s newsroom at https://ibn.fm/ONAR

• FAVO recently secured an $8 million equity investment to fund growth and accelerate its plan to uplist to the Nasdaq Capital Market
•  The company voluntarily converted all super voting Series C Preferred Shares, simplifying its capital structure and improving governance transparency
• With SMBs turning away from traditional banks, FAVO’s revenue-based lending platform meets rising demand for fast, flexible funding solutions

As inflationary pressures and elevated interest rates strain traditional financing channels, small and medium-sized businesses (“SMBs”) are increasingly seeking alternative funding sources to maintain liquidity and drive growth. Bank approval rates for SMB loans have dropped significantly – from 83% in 2019 to just 68% in 2022 – creating a wide credit gap. This shift has accelerated demand for alternative lending options like merchant cash advances (“MCAs”) and revenue-based financing (“RBF”), which offer faster, more flexible access to capital.

Within this expanding sector, FAVO Capital (OTC: FAVO) stands out as a fintech-driven private credit firm built specifically to meet the evolving needs of underserved SMBs. The company has a multi-prong digital approach, including the development of an advanced digital platform designed to enhance client engagement and streamline funding processes.

Now, with fresh capital and governance reforms, FAVO is preparing for its next big milestone: an uplisting to the Nasdaq Capital Market.

Institutional Confidence Bolsters Growth Strategy

On May 6, 2025, FAVO Capital announced an $8 million Series A Preferred equity investment from Stewards Investment Capital, a global asset manager specializing in fintech and private credit. The investment is a clear signal of institutional confidence in FAVO’s growth trajectory, platform scalability, and strategic vision.

“This funding further positions us to serve the capital needs of underserved SMBs with speed, flexibility, and transparency,” said FAVO CEO Vincent Napolitano. The investment will be used to accelerate SMB lending, strengthen the company’s balance sheet, and expand embedded lending partnerships. It also allows FAVO to restructure a portion of its outstanding debt, increasing its financial agility ahead of its planned Nasdaq uplisting.

Governance Overhaul Reflects Public Market Readiness

Just a week after the funding news, FAVO took another major step toward its Nasdaq ambitions by announcing the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock. This move simplifies the company’s capital structure and aligns voting rights with shareholder-friendly governance standards expected on senior exchanges.

“Converting our Series C Super Voting Shares demonstrates our commitment to transparency, governance and best practices,” said Napolitano. “It’s another important step forward as we align our structure with shareholder and institutional investor expectations.”

By eliminating super voting rights, FAVO has increased accessibility and reduced barriers for potential institutional investors, a crucial element for long-term capital market success.

Riding a Multi-Billion Dollar Lending Wave

The timing of FAVO’s expansion couldn’t be more favorable. The MCA market, valued at $19 billion in 2021, more than doubled from five years prior. Meanwhile, the RBF market is expected to grow from $4.75 billion in 2025 to $14.5 billion by 2034, according to recent projections.

FAVO’s fintech-first approach allows for quick underwriting, dynamic risk assessment, and loan structuring that reflects real-time business conditions far beyond the rigid credit models of traditional banks. With over 10,000 SMBs already served, the company has built a scalable foundation for national growth.

As economic volatility persists and access to bank credit remains constrained, businesses are prioritizing flexibility, speed, and financial partners who understand their day-to-day cash flow dynamics. FAVO’s revenue-based financing options offer exactly that, tying repayments to company revenue and easing pressure during slower months.

Positioned for Public Market Momentum

With a simplified share structure, new institutional capital, and an increasingly vital service offering, FAVO Capital is methodically laying the groundwork for a Nasdaq uplisting. Such a move would elevate the company’s visibility, attract new classes of investors, and unlock greater access to capital for continued expansion.

As SMBs continue to seek more agile, non-bank financing partners, FAVO Capital appears well-positioned to meet that demand while simultaneously transitioning from a small OTC company to a player with national ambitions and institutional credibility.

For more information, visit the company’s website at FAVOCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

• Italian football club Juve Stabia finished 5th in Serie B and reached the semifinals of the Serie A promotion playoffs, recording the highest market value increase in Serie B since March 2025.
• Brera now holds a 38.46% stake in the club, with full FIGC approval for the acquisition.
• Attendance surged, with one match nearly selling out the 7,100-seat stadium, as Juve Stabia games have gained international attention, with broadcasts in the U.S., U.K., and Canada.
• A €5 million (US$5.85 million) subsidy was announced by the Campagna Region for Romeo Menti Stadium refurbishment.

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, is celebrating the strong performance of its Italian football portfolio club, SS Juve Stabia, which reached the semifinals of the Serie A promotion playoffs after finishing fifth in Italy’s Serie B regular season (https://ibn.fm/jhXA6).

Brera agreed to acquire a controlling interest in Juve Stabia in December 2024. Its most recent step in the acquisition was completed in February 2025, giving Brera a 38.46% stake at present. The move received formal approval from the Italian Football Federation (“FIGC”), underscoring compliance with national football governance standards.

As reported by Italian publication MediaNews24, Castellammare di Stabia city officials, fans, and players gathered recently to recognize the club’s standout season. During the celebration, Mayor Luigi Vicinanza announced that the Campagna Region would allocate €5 million (approximately US$5.85 million) toward upgrades for Juve Stabia’s Romeo Menti Stadium (https://ibn.fm/jYbMP).

Brera’s Executive Chairman, Daniel McClory, attributes the uptick to operational improvements and a focused development strategy. “This extraordinary growth reflects both the untapped potential of Juve Stabia and Brera’s value-creation strategy in action,” McClory said. “Our focus on operational alignment, player development, and shareholder governance is already bearing fruit. We’re proud of the progress and even more excited for what lies ahead.”

Fan engagement has also grown. On April 5, Juve Stabia recorded its highest home attendance of the season, drawing 7,000 spectators, just short of the 7,100-seat capacity of the Romeo Menti Stadium (https://ibn.fm/PRH3P).

The club’s growing visibility was further reflected in international broadcasting of its matches, including live coverage of a recent fixture against Cremonese in the U.S., U.K., and Canada (https://ibn.fm/UJ69J).

Juve Stabia, nicknamed “Le Vespe” (The Wasps) and often referred to as the “Second Team of Naples,” has become a focal point in Brera’s strategy to build a scalable sports investment portfolio. The near-promotion to Serie A, Italy’s top-tier football league, highlights both competitive potential and commercial opportunity.

Brera’s approach emphasizes long-term value, operational governance, and community engagement. Its investment in Juve Stabia appears to be paying early dividends, not only in performance but also in raising the club’s market profile.

“Brera Holdings is proud to be a significant shareholder of Juve Stabia and congratulates Le Vespe and their supporters for an outstanding return to Serie B, and a breathtaking run into the Serie A playoffs,” said McClory. “The future is very bright for the pride of Castellammare di Stabia.”

For more information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• Financial momentum for Nutriband is indicated by its recent Q1 financial report
• Progress continues development of proprietary AVERSA(TM) Fentanyl, notes quarterly report
• AVERSA(TM) Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch

A wave of positive developments continues to build momentum for Nutriband (NASDAQ: NTRB), with recent capital funding, strategic partnerships and an expanded intellectual property portfolio reinforcing its bid to lead in the development of safer transdermal therapies. Nutriband is positioning itself at the forefront of abuse-deterrent drug delivery by advancing its Aversa platforms, notably its flagship fentanyl patch and buprenorphine candidates.

Financial momentum for Nutriband is indicated by its recent Q1 financial report (ibn.fm/8R0ca), which noted that the company posted record Q1 2025 revenue of $667,000 — a 63% year-over-year increase — driven by expansion in its kinesiology tape manufacturing via subsidiary Pocono Pharma and growing retail sales at Target, Walmart, Walgreens and CVS.

The company also reported that it is continuing to expand its kinesiology tape output through its Pocono Pharma subsidiary, with a continued focus on penetration pricing to gain a foothold with some of the industry’s largest brands. “Progress continues on the development of AVERSA Fentanyl, with the company formalizing an exclusive product development partnership with Kindeva Drug Delivery,” the report stated. “The formalized partnership with Kindeva Drug Delivery reflects a commitment to shared development costs in exchange for milestone payments, enabling Nutriband to advance its innovative transdermal drug-delivery solutions towards regulatory approval and commercialization.”

The company’s momentum began last year with a notable milestone: the closing of an $8.4 million private placement earmarked to fund AVERSA(TM) Fentanyl’s full-scale commercial development ahead of an expected 2025 NDA submission (ibn.fm/9SZ8B). The company is working with Kindeva, an FDA-approved contract development and manufacturing organization (“CDMO”), to integrate its transdermal abuse-deterrent technology into Kindeva’s existing fentanyl patch. The goal is a best-in-class 505(b)(2) application supported by a single phase 1 human abuse-potential study, bypassing the usual phase 2 and 3 trials.

“AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches,” the company stated. “AVERSA(TM) Fentanyl has the potential to reach peak annual U.S. sales of $80 million to $200 million.”

Alongside fentanyl, Nutriband is advancing AVERSA(TM) Buprenorphine, projected to achieve peak U.S. sales between $70 million and $130 million upon approval (https://ibn.fm/mIHdw). Like its counterpart, AVERSA Buprenorphine benefits from Nutriband’s scalable abuse-deterrent platform, and the technology is being positioned for global patent protection.

Nutriband’s forward trajectory is clear: combining transdermal innovation with abuse-deterrent science to meet critical public health needs. With its commercial infrastructure and pipeline expansion, the company is paving a path toward safer opioid management. As the opioid crisis continues, Nutriband’s leadership in transdermal patch technology offers a promising model for improving patient safety without sacrificing efficacy.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• The private credit market has experienced remarkable growth over the past decade, evolving from a niche segment to a cornerstone of the financial ecosystem
• FAVO Capital offers a range of financing options, including revenue-based funding and merchant cash advances
• The company’s impact is reflected in its impressive track record of supporting 10,000-plus small businesses, deploying more than $138 million in capital nationwide

In today’s increasingly fragile economic landscape, small and mid-sized businesses (“SMBs”) face mounting challenges in securing the funding necessary for growth and sustainability. Traditional banks, constrained by stringent regulations and risk-averse policies, often fall short in meeting the unique financial needs of these enterprises. This funding gap has paved the way for alternative financing solutions, with private credit emerging as a vital lifeline. Among the key players in this space is FAVO Capital (OTC: FAVO).

The private credit market has experienced remarkable growth over the past decade, evolving from a niche segment to a cornerstone of the financial ecosystem. According to Preqin, private credit assets under management have surged from $500 billion in 2013 to more than $1.7 trillion in 2025, reflecting a compound annual growth rate of approximately 14% (ibn.fm/Tda5P). This expansion is driven by the increasing demand for flexible, non-bank financing options, particularly among SMBs that are underserved by traditional lenders.

SMBs are the backbone of the global economy, accounting for a significant share of employment and GDP. However, they often encounter barriers when seeking financing through conventional channels, such as lengthy approval processes, rigid collateral requirements and limited loan customization. Private credit providers address these challenges by offering tailored financing solutions that align with the specific needs and risk profiles of SMBs. This approach not only enhances access to capital but also fosters innovation and competitiveness within the SMB sector.

FAVO stands out as a leading private credit provider, specializing in delivering fast, efficient and personalized funding solutions to SMBs across the United States and the Dominican Republic (ibn.fm/r3G1p). Leveraging advanced technology and data-driven underwriting processes, FAVO Capital offers a range of financing options, including revenue-based funding and merchant cash advances, designed to accommodate the diverse financial requirements of SMBs.

The company’s commitment to innovation is evident in its integration of fintech solutions that streamline the lending process, enabling quicker decision-making and disbursement of funds. By harnessing artificial intelligence and machine learning algorithms, FAVO Capital enhances its risk assessment capabilities, ensuring more accurate and efficient credit evaluations. This technological edge not only improves the borrower’s experience but also strengthens the company’s portfolio performance (ibn.fm/wSxBW).

FAVO Capital’s impact is reflected in its impressive track record of supporting more than 10,000 small businesses and deploying more than $138 million in capital nationwide (ibn.fm/UEjm1). The company’s strategic focus on underserved markets and commitment to fostering long-term partnerships with clients underscore its role as a catalyst for SMB growth and resilience.

As the private credit market continues to evolve, FAVO Capital is poised to capitalize on emerging opportunities and expand its footprint. The company’s recent initiatives, including a $8 million Series A preferred investment and plans to uplist to the Nasdaq, signal a strong trajectory of growth and institutional engagement (ibn.fm/vEfc4). By staying at the forefront of industry trends and maintaining a client-centric approach, FAVO Capital exemplifies the transformative potential of private credit in empowering SMBs and driving economic progress.

For more information, visit the company’s website at FAVOCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO